ZOLI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 29.359
EU - Europa 15.728
AS - Asia 13.586
SA - Sud America 1.937
AF - Africa 184
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 23
Totale 60.854
Nazione #
US - Stati Uniti d'America 29.004
GB - Regno Unito 5.516
CN - Cina 4.553
SG - Singapore 4.463
DE - Germania 3.348
IT - Italia 2.410
HK - Hong Kong 1.749
BR - Brasile 1.565
SE - Svezia 1.353
RU - Federazione Russa 908
VN - Vietnam 707
TR - Turchia 686
KR - Corea 654
UA - Ucraina 641
FI - Finlandia 494
BG - Bulgaria 259
FR - Francia 207
CA - Canada 200
AR - Argentina 161
ID - Indonesia 155
IN - India 128
NL - Olanda 91
JP - Giappone 81
ZA - Sudafrica 80
MX - Messico 78
BD - Bangladesh 64
IE - Irlanda 64
BE - Belgio 59
PL - Polonia 58
EC - Ecuador 56
ES - Italia 54
MY - Malesia 51
LT - Lituania 44
IQ - Iraq 40
AT - Austria 39
CO - Colombia 39
IR - Iran 39
RO - Romania 36
AU - Australia 34
CL - Cile 30
PY - Paraguay 29
CH - Svizzera 26
MA - Marocco 26
CZ - Repubblica Ceca 22
UZ - Uzbekistan 22
IL - Israele 21
VE - Venezuela 20
AE - Emirati Arabi Uniti 19
EU - Europa 19
AN - Antille olandesi 18
PK - Pakistan 17
KE - Kenya 16
TH - Thailandia 15
UY - Uruguay 15
EG - Egitto 13
KZ - Kazakistan 13
PE - Perù 13
PH - Filippine 13
PT - Portogallo 12
SA - Arabia Saudita 12
TN - Tunisia 12
NO - Norvegia 11
AL - Albania 10
DZ - Algeria 10
RS - Serbia 10
AZ - Azerbaigian 9
DO - Repubblica Dominicana 9
GE - Georgia 9
JO - Giordania 9
LB - Libano 9
NP - Nepal 9
BO - Bolivia 8
JM - Giamaica 8
CU - Cuba 7
LU - Lussemburgo 7
LV - Lettonia 7
DK - Danimarca 6
HN - Honduras 6
OM - Oman 6
PA - Panama 6
GR - Grecia 5
HU - Ungheria 5
MK - Macedonia 5
SN - Senegal 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BH - Bahrain 4
BY - Bielorussia 4
ET - Etiopia 4
KG - Kirghizistan 4
NI - Nicaragua 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
EE - Estonia 3
GA - Gabon 3
IS - Islanda 3
KH - Cambogia 3
SY - Repubblica araba siriana 3
Totale 60.806
Città #
Southend 4.246
Fairfield 3.117
Santa Clara 2.824
Hefei 2.327
Ashburn 2.242
Woodbridge 2.103
Singapore 2.087
Chandler 1.981
Houston 1.797
Hong Kong 1.736
Jacksonville 1.350
Ann Arbor 1.105
Seattle 1.089
Wilmington 1.072
Dearborn 1.013
Cambridge 978
Nyköping 810
London 674
Seoul 621
Chicago 575
Beijing 536
Modena 514
Los Angeles 491
Como 429
Izmir 400
Princeton 300
San Diego 287
Ho Chi Minh City 258
Sofia 257
Helsinki 249
New York 249
Buffalo 248
The Dalles 235
Eugene 231
Council Bluffs 207
Moscow 160
Hanoi 153
Munich 152
Des Moines 138
Shanghai 135
Redwood City 129
Milan 127
Columbus 125
São Paulo 125
Salt Lake City 116
Jakarta 103
Falls Church 97
Bologna 92
Dallas 82
Ottawa 78
Kocaeli 67
Elk Grove Village 65
Boardman 64
Guangzhou 64
Tokyo 62
Kent 61
Norwalk 59
Rome 57
Dublin 56
Brussels 54
Philadelphia 53
Tampa 52
Bremen 51
Johannesburg 50
Rio de Janeiro 49
Tulare 49
Frankfurt am Main 47
Toronto 45
Stockholm 44
Brooklyn 43
Warsaw 42
Redondo Beach 38
Belo Horizonte 37
Kunming 36
Montreal 35
Nanjing 35
Atlanta 34
Phoenix 33
San Francisco 32
Brasília 31
Fremont 31
Nuremberg 30
Kilburn 28
Parma 28
Reggio Emilia 28
San Mateo 28
Turku 28
Chennai 27
Boston 26
Sterling 26
Zhengzhou 26
Indiana 25
Lancaster 25
Changsha 24
Washington 24
Amsterdam 23
Denver 23
Jinan 23
Quito 23
Da Nang 22
Totale 42.413
Nome #
Neuroscienze e libero arbitrio 624
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 391
D2R–striatopallidal neurons inhibit both locomotor and drug reward processes 388
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 387
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 362
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 342
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 340
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats 332
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 332
Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function. 331
7-Chloro-5-(furan-3-yl)-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-Dioxide as Positive Allosteric Modulator of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor. The End of the Unsaturated-Inactive Paradigm? 331
Whole organic electronic synapses for dopamine detection 319
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 319
Developmental overfeeding alters hypothalamic neuropeptide mRNA levels and response to a high-fat diet in adult mice 317
Age-related alterations in tanycytes of the mediobasal hypothalamus of the male rat 316
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 313
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice 313
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: Design, synthesis and pharmacological characterization 313
Exploiting interfacial phenomena in organic bioelectronics: Conformable devices for bidirectional communication with living systems 312
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 312
Loss of high-affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment 308
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 308
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 308
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 307
Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period 306
Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum 301
Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum. 300
Effects of neurotoxic and mechanical lesions of the mesostriatal dopamine pathway on striatal polyamine levels in the rat: modulation by chronic ganglioside GM1 treatment. 298
Simultaneous measurement of adenosine, dopamine, acetylcholine and 5-hydroxytryptamine in cerebral mice microdialysis samples by LC–ESI-MS/MS 295
Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats. 294
Specific Dopamine Sensing Based on Short-Term Plasticity Behavior of a Whole Organic Artificial Synapse 294
Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors 294
D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release. 292
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice 292
Wiring and volume transmission in the central nervous system: The concept of closed and open synapses 291
Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides. 290
Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats 290
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes 289
The emergence of the volume transmission concept 286
Regional and cellular distribution of spermidine/spermine N-1-acetyltransferase (SSAT) mRNA in the rat central nervous system 286
Diet-induced changes in hypothalamic pro-opio-melanocortin mRNA in the rat hypothalamus 285
Intercellular communication in the brain: Wiring versus volume transmission 284
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 280
Cellular and synaptic alterations in the aging brain. 279
Diversity of native nicotinic receptor subtypes in mammalian brain 279
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the rat. 278
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. 277
Degenerazione e rigenerazione nel sistema nervoso centrale: rilevanza dei fattori trofici e della trasmissione neuronale colinergica nel trofismo del sistema nervoso centrale. 277
Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence. 276
Spermidine/spermine N-1-acetyltransferase mRNA levels show marked and region-specific changes in the early phase after transient forebrain ischemia 275
Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia 273
Heterogeneity and complexity of native brain nicotinic receptors 273
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 273
Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments 273
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 272
Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections 271
Corticosterone treatment counteracts lesions induced by neonatal treatment with monosodium glutamate in the mediobasal hypothalamus of the male rat 271
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. 271
l-Glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes. 271
Neuromorphic Organic Devices that Specifically Discriminate Dopamine from Its Metabolites by Nonspecific Interactions 270
MicroRNA-101 Regulates Multiple Developmental Programs to Constrain Excitation in Adult Neural Networks 269
Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice 269
"Heart-cut" bidimensional achiral-chiral liquid chromatography applied to the evaluation of stereoselective metabolism, in vivo biological activity and brain response to chiral drug candidates targeting the central nervous system 268
Volume transmission in the CNS and its relevance for neuropsychopharmacology 268
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 268
Changes in nicotinic acetylcholine receptor subunit mRNAs and nicotinic binding in spontaneously hypertensive stroke prone rats 268
MAPPING AND COMPUTER-ASSISTED MORPHOMETRY AND MICRODENSITOMETRY OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVE NEURONS AND GLIAL-CELLS IN THE RAT CENTRAL-NERVOUS-SYSTEM 266
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 266
SELECTIVE REDUCTION OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVITY IN THE HIPPOCAMPAL-FORMATION AND CENTRAL AMYGDALOID NUCLEUS OF THE AGED RAT 265
In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 265
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 265
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice 264
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain 264
Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats 263
Evidence for the existence of ornithine decarboxylase-immunoreactive neurons in the rat brain. 263
Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner 263
The receptor mosaic hypothesis of the engram: Possible relevance of Boolean network modeling 262
Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate. 261
Nicotine and neurodegeneration in ageing 260
Studies on the cellular localization and distribution of glucocorticoid receptor and estrogen receptor immunoreactivity in the central nervous system of the rat and their relationship to the monoaminergic and peptidergic neurons of the brain. 260
Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat 260
An improved LC-S/MS method for the quantitation of adenosine concentration in mice brain microdialysates 258
Studies on neurotensin catecholamine interactions in the hypothalamus and in the forebrain of the male rat. 258
Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive nerve terminals and on glucocorticoid receptor-immunoreactive nerve cell nuclei in the paraventricular hypothalamic nucleus in adult and old male rats. 258
Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat 257
Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice 257
Intravenous uridine treatment antagonizes hypoglycaemia-induced reduction in brain somatostatin-like immunoreactivity. 257
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 257
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .1. COMPUTER-ASSISTED IMAGE-ANALYSIS METHODS 256
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 256
REGIONAL AND CELLULAR-DISTRIBUTION WITHIN THE RAT PROSTATE OF 2 MESSENGER-RNA SPECIES UNDERGOING OPPOSITE REGULATION BY ANDROGENS 254
Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain 254
Transient forebrain ischemia produces multiple deficits in dopamine D1 transmission in the lateral neostriatum of the rat. 254
REGIONAL INCREASES IN ORNITHINE DECARBOXYLASE MESSENGER-RNA LEVELS IN THE RAT-BRAIN AFTER PARTIAL MESODIENCEPHALIC HEMITRANSECTION AS REVEALED BY INSITU HYBRIDIZATION HISTOCHEMISTRY 253
Central mechanisms subserving the impaired growth hormone secretion induced by persistent blockade of NMDA receptors in immature male rats. 253
Neuron-glia cross talk in rat striatum after transient forebrain ischemia 252
Evidence for discrete alterations in central cardiovascular catecholamine and neuropeptide Y immunoreactive neurons in aged male rats and in genetically hypertensive male rats of the Lyon strain. 251
A NEW MODEL OF FOCAL BRAIN ISCHEMIA BASED ON THE INTRACEREBRAL INJECTION OF ENDOTHELIN-1 251
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 250
Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors 249
Totale 28.823
Categoria #
all - tutte 234.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.291 0 0 0 0 0 530 868 730 182 1.347 359 275
2021/20225.148 124 622 521 308 137 227 315 296 571 370 942 715
2022/20234.947 649 629 461 427 543 724 73 474 585 45 208 129
2023/20242.759 121 190 322 262 534 270 189 322 67 61 121 300
2024/202513.151 638 115 147 815 2.098 1.595 957 682 1.073 1.292 2.130 1.609
2025/202610.124 1.794 1.154 1.958 2.110 2.585 523 0 0 0 0 0 0
Totale 61.231